Findings

What do systematic reviews say?

3,454 questions · 3,562 findings · 816 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 538 · 15.1%GRADE not reported 239 · 6.7%Very low 933 · 26.2%Low 1,041 · 29.2%Moderate 612 · 17.2%High 199 · 5.6%

Intervention not reported

Number of participants symptomatic after 7 days of treatment · patients with common cold

It is very uncertain whether the intervention changes number of participants symptomatic after 7 days of treatment (very low certainty).

1 finding from 1 review

Zinc for the common cold 2013 · Cochrane Headline outcomes only
OR 0.45 [0.2, 1]
5 studies · 476 participants
Very low

Intervention not reported

School absence (number of days) · patients with common cold

1 finding from 1 review

Zinc for the common cold 2013 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 394 participants
Very low

Iron therapy vs placebo

Bayley Scale PDI within 30 days of commencement of therapy · children less than 3 years of age with iron deficiency anaemia

1 finding from 1 review

Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron… 2013 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 162 participants
Low

Iron therapy vs placebo

Bayley Scale MDI within 30 days of commencement of therapy · children less than 3 years of age with iron deficiency anaemia

1 finding from 1 review

Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron… 2013 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 164 participants
Low

Iron therapy vs placebo

Bayley Scale PDI more than 30 days of commencement of therapy · children less than 3 years of age with iron deficiency anaemia

1 finding from 1 review

Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron… 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 47 participants
Moderate

Iron therapy vs placebo

Bayley Scale MDI more than 30 days of commencement of therapy · children less than 3 years of age with iron deficiency anaemia

1 finding from 1 review

Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron… 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 47 participants
Moderate

Iron therapy vs placebo

Denver Developmental Screening Test more than 30 days of commencement of therapy · children less than 3 years of age with iron deficiency anaemia

1 finding from 1 review

Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron… 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 97 participants
Moderate

Different doses of GnRHa depot vs GnRHa daily injection

Number of days of gonadotrophin treatment ‐ half dose · women undergoing pituitary suppression in assisted reproduction

1 finding from 1 review

Depot versus daily administration of gonadotrophin‐releasing hormone agonist protocols for pituitary down regulation… 2013 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 507 participants
Low

Different doses of GnRHa depot vs GnRHa daily injection

Number of days of gonadotrophin treatment ‐ full dose · women undergoing pituitary suppression in assisted reproduction

1 finding from 1 review

Depot versus daily administration of gonadotrophin‐releasing hormone agonist protocols for pituitary down regulation… 2013 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 526 participants
Low

Intervention not reported

Length of stay (days) · saving healthcare resources

1 finding from 1 review

Computerized advice on drug dosage to improve prescribing practice 2013 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 18507 participants
Very low

Intervention not reported

Length of stay (days) ‐ oral anticoagulants · saving healthcare resources

1 finding from 1 review

Computerized advice on drug dosage to improve prescribing practice 2013 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 105 participants
Very low

Intervention not reported

Length of stay (days) ‐ insulin · saving healthcare resources

1 finding from 1 review

Computerized advice on drug dosage to improve prescribing practice 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 128 participants
High

Intervention not reported

Length of stay (days) ‐ theophylline · saving healthcare resources

1 finding from 1 review

Computerized advice on drug dosage to improve prescribing practice 2013 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 151 participants
Low

Intervention not reported

Length of stay (days) ‐ aminoglycoside antibiotics · saving healthcare resources

1 finding from 1 review

Computerized advice on drug dosage to improve prescribing practice 2013 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 295 participants
Moderate

Intervention not reported

Length of stay (days) ‐ anti‐rejection drugs · saving healthcare resources

1 finding from 1 review

Computerized advice on drug dosage to improve prescribing practice 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 17828 participants
Moderate

Intervention not reported

Proportion of participants within therapeutic range ‐ aminoglycoside antibiotics: % of participants with peak concentrations adequate after 2 days · patients with leading serum concentrations within therapeutic range

The intervention probably leads to higher proportion of participants within therapeutic range ‐ aminoglycoside… (moderate certainty).

1 finding from 1 review

Computerized advice on drug dosage to improve prescribing practice 2013 · Cochrane Headline outcomes only
RR 4.44 [1.94, 10.13]
2 studies · 72 participants
Moderate

Intervention not reported

Time to achieve therapeutic range ‐ oral anticoagulants: time to achieve therapeutic prothrombin ratio (days) · patients with reducing time to achieve therapeutic control

1 finding from 1 review

Computerized advice on drug dosage to improve prescribing practice 2013 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 223 participants
Low

Intervention not reported

Time to stabilization ‐ oral anticoagulants: time to stabilization (days) · patients with reducing time to achieve therapeutic control

1 finding from 1 review

Computerized advice on drug dosage to improve prescribing practice 2013 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 255 participants
Very low

Hepatic resection vs radiofrequency ablation

Length of hospital stay · 578 patients with early HCC

1 finding from 1 review

Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma 2013 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 578 participants
High

LC + LCBDE vs pre‐operative ERCP + LC

Mortality at 30 days · with common bile duct stones

LC + LCBDE showed no clear difference in mortality at 30 days compared with pre‐operative ERCP + LC (moderate certainty).

1 finding from 1 review

Surgical versus endoscopic treatment of bile duct stones 2013 · Cochrane Headline outcomes only
OR 0.72 [0.12, 4.33]
5 studies · 580 participants
Moderate